Nymox Pharmaceutical (NYMXF) Share-based Compensation (2017 - 2024)
Nymox Pharmaceutical (NYMXF) recorded Share-based Compensation of $1.71 million in FY2025, up 154.5% from $671,000 in FY2024.
Powered by 
Analysis
Nymox Pharmaceutical (NYMXF) Share-based Compensation (2017 - 2024) Analysis & Trends
Starting with FY2015, Nymox Pharmaceutical's Share-based Compensation history includes 11 years.
- Annual Share-based Compensation has a five-year compound annual growth rate of -0.5% (FY2020 to FY2025).
- Annual Share-based Compensation has ranged from $593,000 in FY2022 to $3.36 million in FY2023 over the past five years.
- Per Business Quant data, NYMXF's Share-based Compensation was $671,000 in FY2024 (-80.0%), $3.36 million in FY2023 (+466.1%), $593,000 in FY2022 (-77.2%) and $2.6 million in FY2021 (+48.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Nymox Pharmaceutical | 5.76 Mn | 5.57 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 159,000.00 |
| Dec 31, 2023 | 3.24 Mn |
| Sep 30, 2023 | 11,000.00 |
| Jun 30, 2023 | 32,000.00 |
| Mar 31, 2023 | 70,000.00 |
| Dec 31, 2022 | 84,000.00 |
| Sep 30, 2022 | 33,000.00 |
| Jun 30, 2022 | 382,000.00 |
| Mar 31, 2022 | 94,000.00 |
| Dec 31, 2021 | 721,000.00 |
| Sep 30, 2021 | 174,000.00 |
| Jun 30, 2021 | 1.43 Mn |
| Mar 31, 2021 | 282,000.00 |
| Dec 31, 2020 | 329,000.00 |
| Sep 30, 2020 | 376,000.00 |
| Jun 30, 2020 | 435,000.00 |
| Mar 31, 2020 | 608,000.00 |
| Dec 31, 2019 | 485,000.00 |
| Sep 30, 2019 | 546,000.00 |
| Jun 30, 2019 | 1.29 Mn |
API Access
Nymox Pharmaceutical Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NYMXF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "NYMXF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NYMXF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();